AZ’s Asthma Drug Tezepelumab Up for MHLW Panel Review on August 29

August 17, 2022
A key health ministry panel will discuss whether to put forward a host of new medicines for approval at its upcoming meeting on August 29 including AstraZeneca’s asthma drug tezepelumab. If given the green light, they would land official approval...read more